Cite
HARVARD Citation
Shang, L. et al. (2019). The caveolin‐3 P104L mutation in LGMD‐1C patients inhibits non‐insulin‐stimulated glucose metabolism and growth but promotes myocyte proliferation. Cell biology international. pp. 669-677. [Online].